Related Experiment Video
Updated: Jun 11, 2025

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Medin, a link between vascular pathology and dementia?
Ilse S Altenburg1, Nina G Smets1,2,3, Gustav J Strijkers1,2
1Department of Biomedical Engineering and Physics, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Abstract:
Medin is a protein fragment derived from milk fat globule epidermal growth factor VIII (MFG-E8). Medin aggregates are present in the vessel wall of most subjects over 50 years of age. In this narrative review, we focus on the consequences of medin aggregation in relation to the development of dementia. Recent literature revealed medin as biomarker for dementia in CSF, specifically of a vascular subtype. Preclinical work showed that medin is associated with aging-related cerebral vascular dysfunction, vascular stiffening, hypertension, and. vascular amyloid β deposition. These findings position medin as a potential mechanistic link between aging, vascular pathology and dementia.
Insights
Medin, a protein fragment, aggregates in blood vessels with age and is linked to dementia. It may be a key factor connecting aging, vascular issues, and cognitive decline.
Area of Science:
- Neuroscience
- Gerontology
- Biochemistry
Background:
- Medin is a protein fragment originating from milk fat globule epidermal growth factor VIII (MFG-E8).
- Medin aggregates are observed in the vessel walls of individuals over 50.
- Dementia is a growing concern, particularly in aging populations.
Purpose of the Study:
- To review the role of medin aggregation in the development of dementia.
- To explore medin as a potential biomarker for vascular dementia.
- To understand the mechanistic link between medin, aging, and cerebrovascular pathology.
Main Methods:
- This is a narrative review of existing literature.
- Analysis of preclinical studies on medin's association with aging and vascular factors.
- Examination of studies identifying medin as a cerebrospinal fluid (CSF) biomarker for dementia.
Main Results:
- Medin aggregation is prevalent in aging individuals.
- Medin is identified as a CSF biomarker for a vascular subtype of dementia.
- Preclinical data links medin to aging-related cerebral vascular dysfunction, stiffening, hypertension, and amyloid-beta deposition.
Conclusions:
- Medin aggregation is associated with aging and vascular pathology.
- Medin shows potential as a biomarker for vascular dementia.
- Medin may serve as a mechanistic link between aging, vascular disease, and dementia development.
More Related Videos
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Peripheral Artery Disease I: Introduction

